Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 324 Results
Palatin Presents Data on Novel Melanocortin 4 Receptor Selective Oral Small Molecule PL7737 Obesity Program at ObesityWeek® 2024
November 4, 2024
Inflammatory Disease Healing Data via Palatin’s Novel Melanocortin Receptor Agonists Presented at the 19th Annual Peptide Therapeutics Symposium
October 24, 2024
Palatin Presents Foundational Data on Novel and Highly Selective Melanocortin 4 Receptor Agonists at the 19th Annual Peptide Therapeutics Symposium
October 23, 2024
Palatin Receives Notice of Non-Compliance from NYSE American
October 7, 2024
Palatin to Report Fourth Quarter and Fiscal Year End 2024 Results
September 26, 2024
Palatin Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones
September 9, 2024
Page 2 of 33